Market cap: $
Exchange: NAS
Sector: Health Technology
Agile Therapeutics, Inc. is a healthcare company, which engages in the development and commercialization of transdermal patch. Its lead product candidate, Twirla, also known as AG200-15, is an investigational low-dose, non-daily prescription contraceptive. The company was founded by Chien Te Yen on December 22, 1997 and is headquartered in Princeton, NJ.
Company Name
Agile Therapeutics Inc
Average Volume (10 days)
0
Average Volume (30 days)
0
Moving Average (50 days)
$0
Moving Average (200 days)
$0
Ex-Divided Date
n/a
Dividend Yield
0
P/E Ratio
0
Market Cap
0
Shares Outstanding
6,856,229
52-Week High Split Adjust Only
0
52-Week Low Split Adjust Only
0
Employee Count
44
Beta
0
Next Earnings Date
2024-05-15
TTM Dividend Rate Per Share
0
Past 5 days
0%
Past 30 days
0%
Past 3 months
0%
Past 6 months
0%
Past year
0%
Past 2 years
0%
Past 5 years
0%
Max % Change
0%
| Name | Ticker | Price/Sales (ttm) | Price/Book (ttm) | Forward P/E | PEG Ratio | EV/Revenue |
|---|---|---|---|---|---|---|
| Agile Therapeutics Inc | AGRX | n/a | n/a | -2.3 | n/a | n/a |
| Peer Avg | N/A | 5.18 | -8.29 | 4.7 | 5.18 | 5.64 |
| Johnson & Johnson | JNJ | 5.29 | 6.77 | n/a | 5.29 | 5.40 |
| Merck & Co Inc | MRK | 4.00 | 7.13 | 11.7 | 4.00 | 4.51 |
| Pfizer Inc. | PFE | 4.88 | 3.16 | 10.2 | 4.88 | 5.46 |
| TherapeuticsMD Inc | TXMD | 6.56 | -50.20 | -3.1 | 6.56 | 7.20 |